Literature DB >> 33396572

The Role of Bone in Muscle Wasting.

Gordon L Klein1.   

Abstract

This review describes the role of bone resorption in muscle atrophy as well as in muscle protein anabolism. Both catabolic and anabolic pathways involve components of the proinflammatory cytokine families and release of factors stored in bone during resorption. The juxtaposition of the catabolic and anabolic resorption-dependent pathways raises new questions about control of release of factors from bone, quantity of release in a variety of conditions, and relation of factors released from bone. The catabolic responses involve release of calcium from bone into the circulation resulting in increased inflammatory response in intensity and/or duration. The release of transforming growth factor beta (TGF-β) from bone suppresses phosphorylation of the AKT/mTOR pathway and stimulates ubiquitin-mediated breakdown of muscle protein. In contrast, muscle IL-6 production is stimulated by undercarboxylated osteocalcin, which signals osteoblasts to produce more RANK ligand, stimulating resorptive release of undercarboxylated osteocalcin, which in turn stimulates muscle fiber nutrient uptake and an increase in muscle mass.

Entities:  

Keywords:  bone resorption; calcium; inflammation; muscle atrophy; transforming growth factor β

Mesh:

Year:  2020        PMID: 33396572      PMCID: PMC7795218          DOI: 10.3390/ijms22010392

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  34 in total

1.  Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA.

Authors:  P K Nielsen; A K Rasmussen; R Butters; U Feldt-Rasmussen; K Bendtzen; R Diaz; E M Brown; K Olgaard
Journal:  Biochem Biophys Res Commun       Date:  1997-09-29       Impact factor: 3.575

2.  Myostatin and carbohydrate disturbances.

Authors:  Yavor S Assyov; Tsvetelina V Velikova; Zdravko A Kamenov
Journal:  Endocr Res       Date:  2016-06-29       Impact factor: 1.720

3.  Dysregulation of calcium homeostasis after severe burn injury in children: possible role of magnesium depletion.

Authors:  G L Klein; M Nicolai; C B Langman; B F Cuneo; D E Sailer; D N Herndon
Journal:  J Pediatr       Date:  1997-08       Impact factor: 4.406

4.  RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass.

Authors:  Nicolas Bonnet; Lucie Bourgoin; Emmanuel Biver; Eleni Douni; Serge Ferrari
Journal:  J Clin Invest       Date:  2019-05-23       Impact factor: 14.808

5.  Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise.

Authors:  Paula Mera; Kathrin Laue; Mathieu Ferron; Cyril Confavreux; Jianwen Wei; Marta Galán-Díez; Alain Lacampagne; Sarah J Mitchell; Julie A Mattison; Yun Chen; Justine Bacchetta; Pawel Szulc; Richard N Kitsis; Rafael de Cabo; Richard A Friedman; Christopher Torsitano; Timothy E McGraw; Michelle Puchowicz; Irwin Kurland; Gerard Karsenty
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

6.  Evidence supporting a role of glucocorticoids in short-term bone loss in burned children.

Authors:  Gordon L Klein; Lin Xiang Bi; Donald J Sherrard; Sian R Beavan; Deborah Ireland; Juliet E Compston; W Geoffrey Williams; David N Herndon
Journal:  Osteoporos Int       Date:  2004-02-27       Impact factor: 4.507

7.  Temporal cytokine profiles in severely burned patients: a comparison of adults and children.

Authors:  Celeste C Finnerty; Marc G Jeschke; David N Herndon; Richard Gamelli; Nicole Gibran; Matthew Klein; Geoff Silver; Brett Arnoldo; Daniel Remick; Ronald G Tompkins
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

8.  Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors.

Authors:  Manuela Rossol; Matthias Pierer; Nora Raulien; Dagmar Quandt; Undine Meusch; Kathrin Rothe; Kristin Schubert; Torsten Schöneberg; Michael Schaefer; Ute Krügel; Sanela Smajilovic; Hans Bräuner-Osborne; Christoph Baerwald; Ulf Wagner
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

9.  Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia.

Authors:  Brian A Hain; Haifang Xu; Jenna R Wilcox; Daniel Mutua; David L Waning
Journal:  JCSM Rapid Commun       Date:  2019 Jan-Jun

10.  Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice.

Authors:  Alyson L Essex; Fabrizio Pin; Joshua R Huot; Lynda F Bonewald; Lilian I Plotkin; Andrea Bonetto
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-19       Impact factor: 5.555

View more
  1 in total

1.  Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial.

Authors:  Søren Gam; Bibi Gram; Claus Bogh Juhl; Anne Pernille Hermann; Stinus Gadegaard Hansen
Journal:  Trials       Date:  2022-10-08       Impact factor: 2.728

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.